Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply..
Post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS) is a disabling disorder, yet the clinical phenotype is poorly defined, the pathophysiology is unknown, and no disease-modifying treatments are available. We used rigorous criteria to recruit PI-ME/CFS participants with matched controls to conduct deep phenotyping. Among the many physical and cognitive complaints, one defining feature of PI-ME/CFS was an alteration of effort preference, rather than physical or central fatigue, due to dysfunction of integrative brain regions potentially associated with central catechol pathway dysregulation, with consequences on autonomic functioning and physical conditioning. Immune profiling suggested chronic antigenic stimulation with increase in naïve and decrease in switched memory B-cells. Alterations in gene expression profiles of peripheral blood mononuclear cells and metabolic pathways were consistent with cellular phenotypic studies and demonstrated differences according to sex. Together these clinical abnormalities and biomarker differences provide unique insight into the underlying pathophysiology of PI-ME/CFS, which may guide future intervention.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Nature communications - 15(2024), 1 vom: 21. Feb., Seite 907 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.02.2024 Date Revised 24.02.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41467-024-45107-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368734676 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368734676 | ||
| 003 | DE-627 | ||
| 005 | 20240229150227.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240222s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41467-024-45107-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1304.xml |
| 035 | |a (DE-627)NLM368734676 | ||
| 035 | |a (NLM)38383456 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Walitt, Brian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.02.2024 | ||
| 500 | |a Date Revised 24.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. | ||
| 520 | |a Post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS) is a disabling disorder, yet the clinical phenotype is poorly defined, the pathophysiology is unknown, and no disease-modifying treatments are available. We used rigorous criteria to recruit PI-ME/CFS participants with matched controls to conduct deep phenotyping. Among the many physical and cognitive complaints, one defining feature of PI-ME/CFS was an alteration of effort preference, rather than physical or central fatigue, due to dysfunction of integrative brain regions potentially associated with central catechol pathway dysregulation, with consequences on autonomic functioning and physical conditioning. Immune profiling suggested chronic antigenic stimulation with increase in naïve and decrease in switched memory B-cells. Alterations in gene expression profiles of peripheral blood mononuclear cells and metabolic pathways were consistent with cellular phenotypic studies and demonstrated differences according to sex. Together these clinical abnormalities and biomarker differences provide unique insight into the underlying pathophysiology of PI-ME/CFS, which may guide future intervention | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Singh, Komudi |e verfasserin |4 aut | |
| 700 | 1 | |a LaMunion, Samuel R |e verfasserin |4 aut | |
| 700 | 1 | |a Hallett, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Jacobson, Steve |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Kong |e verfasserin |4 aut | |
| 700 | 1 | |a Enose-Akahata, Yoshimi |e verfasserin |4 aut | |
| 700 | 1 | |a Apps, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Barb, Jennifer J |e verfasserin |4 aut | |
| 700 | 1 | |a Bedard, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Brychta, Robert J |e verfasserin |4 aut | |
| 700 | 1 | |a Buckley, Ashura Williams |e verfasserin |4 aut | |
| 700 | 1 | |a Burbelo, Peter D |e verfasserin |4 aut | |
| 700 | 1 | |a Calco, Brice |e verfasserin |4 aut | |
| 700 | 1 | |a Cathay, Brianna |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Li |e verfasserin |4 aut | |
| 700 | 1 | |a Chigurupati, Snigdha |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Jinguo |e verfasserin |4 aut | |
| 700 | 1 | |a Cheung, Foo |e verfasserin |4 aut | |
| 700 | 1 | |a Chin, Lisa M K |e verfasserin |4 aut | |
| 700 | 1 | |a Coleman, Benjamin W |e verfasserin |4 aut | |
| 700 | 1 | |a Courville, Amber B |e verfasserin |4 aut | |
| 700 | 1 | |a Deming, Madeleine S |e verfasserin |4 aut | |
| 700 | 1 | |a Drinkard, Bart |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Li Rebekah |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrucci, Luigi |e verfasserin |4 aut | |
| 700 | 1 | |a Gabel, Scott A |e verfasserin |4 aut | |
| 700 | 1 | |a Gavin, Angelique |e verfasserin |4 aut | |
| 700 | 1 | |a Goldstein, David S |e verfasserin |4 aut | |
| 700 | 1 | |a Hassanzadeh, Shahin |e verfasserin |4 aut | |
| 700 | 1 | |a Horan, Sean C |e verfasserin |4 aut | |
| 700 | 1 | |a Horovitz, Silvina G |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, Kory R |e verfasserin |4 aut | |
| 700 | 1 | |a Govan, Anita Jones |e verfasserin |4 aut | |
| 700 | 1 | |a Knutson, Kristine M |e verfasserin |4 aut | |
| 700 | 1 | |a Kreskow, Joy D |e verfasserin |4 aut | |
| 700 | 1 | |a Levin, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Lyons, Jonathan J |e verfasserin |4 aut | |
| 700 | 1 | |a Madian, Nicholas |e verfasserin |4 aut | |
| 700 | 1 | |a Malik, Nasir |e verfasserin |4 aut | |
| 700 | 1 | |a Mammen, Andrew L |e verfasserin |4 aut | |
| 700 | 1 | |a McCulloch, John A |e verfasserin |4 aut | |
| 700 | 1 | |a McGurrin, Patrick M |e verfasserin |4 aut | |
| 700 | 1 | |a Milner, Joshua D |e verfasserin |4 aut | |
| 700 | 1 | |a Moaddel, Ruin |e verfasserin |4 aut | |
| 700 | 1 | |a Mueller, Geoffrey A |e verfasserin |4 aut | |
| 700 | 1 | |a Mukherjee, Amrita |e verfasserin |4 aut | |
| 700 | 1 | |a Muñoz-Braceras, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Norato, Gina |e verfasserin |4 aut | |
| 700 | 1 | |a Pak, Katherine |e verfasserin |4 aut | |
| 700 | 1 | |a Pinal-Fernandez, Iago |e verfasserin |4 aut | |
| 700 | 1 | |a Popa, Traian |e verfasserin |4 aut | |
| 700 | 1 | |a Reoma, Lauren B |e verfasserin |4 aut | |
| 700 | 1 | |a Sack, Michael N |e verfasserin |4 aut | |
| 700 | 1 | |a Safavi, Farinaz |e verfasserin |4 aut | |
| 700 | 1 | |a Saligan, Leorey N |e verfasserin |4 aut | |
| 700 | 1 | |a Sellers, Brian A |e verfasserin |4 aut | |
| 700 | 1 | |a Sinclair, Stephen |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Bryan |e verfasserin |4 aut | |
| 700 | 1 | |a Snow, Joseph |e verfasserin |4 aut | |
| 700 | 1 | |a Solin, Stacey |e verfasserin |4 aut | |
| 700 | 1 | |a Stussman, Barbara J |e verfasserin |4 aut | |
| 700 | 1 | |a Trinchieri, Giorgio |e verfasserin |4 aut | |
| 700 | 1 | |a Turner, Sara A |e verfasserin |4 aut | |
| 700 | 1 | |a Vetter, C Stephenie |e verfasserin |4 aut | |
| 700 | 1 | |a Vial, Felipe |e verfasserin |4 aut | |
| 700 | 1 | |a Vizioli, Carlotta |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Ashley |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Shanna B |e verfasserin |4 aut | |
| 700 | 0 | |a Center for Human Immunology, Autoimmunity, and Inflammation (CHI) Consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Nath, Avindra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 15(2024), 1 vom: 21. Feb., Seite 907 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g number:1 |g day:21 |g month:02 |g pages:907 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-024-45107-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 |e 1 |b 21 |c 02 |h 907 | ||